StarLink producer Aventis is looking to sell its CropScience unit as it sharpens its focus on pharmaceuticals operations.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more


Aventis staff-management sources said earlier this month that the company had decided to sell rather than float the business. The company is also in the process of selling its animal nutrition unit to CVC Capital Partners, say union sources at the Franco-German group.


Aventis has been touting its CropScience sale proposal to Monsanto, DuPont and Dow as well as German chemical groups Bayer and BASF. Industry sources say that any buyer would have to pay around €3.7bn, plus about €2bn in debt.

Just Food Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Just Food Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving food industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now